These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 35230680)

  • 1. The Architecture of a Precision Oncology Platform.
    Laganà A
    Adv Exp Med Biol; 2022; 1361():1-22. PubMed ID: 35230680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics workflows for clinical applications in precision oncology.
    Jäger N
    Semin Cancer Biol; 2022 Sep; 84():103-112. PubMed ID: 33476720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of precision medicine in modern molecular oncology.
    Wang Y; Zheng D
    Clin Genet; 2021 Sep; 100(3):248-257. PubMed ID: 33997970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyond.
    Edsjö A; Russnes HG; Lehtiö J; Tamborero D; Hovig E; Stenzinger A; Rosenquist R;
    J Intern Med; 2024 Jun; 295(6):785-803. PubMed ID: 38698538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding inequities in precision oncology diagnostics.
    Dutta R; Vallurupalli M; McVeigh Q; Huang FW; Rebbeck TR
    Nat Cancer; 2023 Jun; 4(6):787-794. PubMed ID: 37248397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of cancer next-generation sequencing testing in a community hospital.
    Akkari Y; Smith T; Westfall J; Lupo S
    Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing in precision oncology: challenges and opportunities.
    Kruglyak KM; Lin E; Ong FS
    Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group.
    Yoon S; Kim M; Hong YS; Kim HS; Kim ST; Kim J; Yun H; Yoo C; Ahn HK; Kim HS; Lee IH; Kim IH; Park I; Jeong JH; Cheon J; Kim JW; Yun J; Lim SM; Cha Y; Jang SJ; Zang DY; Kim TW; Kang JH; Kim JH
    Cancer Res Treat; 2022 Jan; 54(1):1-9. PubMed ID: 34902959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of next-generation sequencing in precision oncology.
    Hux A; Lewis A; Sachwitz D; Gregory T
    JAAPA; 2019 Jan; 32(1):35-39. PubMed ID: 30589734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Next Generation Sequencing in Laboratory Medicine.
    Zhong Y; Xu F; Wu J; Schubert J; Li MM
    Ann Lab Med; 2021 Jan; 41(1):25-43. PubMed ID: 32829577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Precision oncology and molecular tumor boards].
    Mack E; Horak P; Fröhling S; Neubauer A
    Inn Med (Heidelb); 2024 May; 65(5):462-471. PubMed ID: 38652307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.
    Ziogas DE; Kyrochristos ID; Roukos DH
    Expert Rev Med Devices; 2018 Jan; 15(1):1-3. PubMed ID: 29284319
    [No Abstract]   [Full Text] [Related]  

  • 13. Matching cancer genomes to established cell lines for personalized oncology.
    Dudley JT; Chen R; Butte AJ
    Pac Symp Biocomput; 2011; ():243-52. PubMed ID: 21121052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial Intelligence for Precision Oncology.
    Bhalla S; Laganà A
    Adv Exp Med Biol; 2022; 1361():249-268. PubMed ID: 35230693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel genes by whole-exome sequencing can improve gastric cancer precision oncology.
    Lianos GD; Glantzounis GK; Bali CD; Katsios C; Roukos DH
    Future Oncol; 2017 Apr; 13(10):883-892. PubMed ID: 27897040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision oncology based on omics data: The NCT Heidelberg experience.
    Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S
    Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
    Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision oncology: a clinical and patient perspective.
    Lassen UN; Makaroff LE; Stenzinger A; Italiano A; Vassal G; Garcia-Foncillas J; Avouac B
    Future Oncol; 2021 Oct; 17(30):3995-4009. PubMed ID: 34278817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Personalized Medicine Here?
    Carneiro BA; Costa R; Taxter T; Chandra S; Chae YK; Cristofanilli M; Giles FJ
    Oncology (Williston Park); 2016 Apr; 30(4):293-303, 307. PubMed ID: 27085327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.